Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05292521

Quality of Life Intervention to Inform Patient Decision-Making in Early-Stage Lung Cancer

Utilizing Patient Reported Quality of Life to Inform Patient Decision Making in Early-Stage Lung Cancer

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
150 (estimated)
Sponsor
Roswell Park Cancer Institute · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This clinical trial studies the effect of a quality of life intervention on decision-making in patients with early-stage lung cancer who are undergoing standard of care surgery or stereotactic body radiation therapy (SBRT). Providing quality of life outcome data to patients deciding between surgery and SBRT may help decrease decision regret and increase patient satisfaction with their care.

Detailed description

PRIMARY OBJECTIVE: I. Determine the effect of provision of quality-of-life (QOL) information versus usual care for standard of care surgery or SBRT treatment on decision regret. SECONDARY OBJECTIVES: I. Determine the effect of provision of QOL information versus usual care for standard of care surgery or SBRT treatment on QOL measures. II. Determine the influence of socioeconomic status on the relationship between decision regret and QOL information associated with each treatment modality. OUTLINE: Patients are randomized to 1 of 2 groups. GROUP A: Patients receive study QOL intervention fact sheet during the initial consult that occurs 4 weeks prior to the standard of care surgery or SBRT. Patients have an opportunity to review the QOL fact sheet in person and discuss any questions with the treating physician(s). GROUP B: Patients receive usual care during the initial consult that occurs 4 weeks prior to the standard of care surgery or SBRT. Patients are followed up at 1, 3, and 6 months after standard of care surgery or SBRT.

Conditions

Interventions

TypeNameDescription
OTHERBest PracticeReceive usual care
OTHERInformational InterventionReceive QOL fact sheet
OTHERQuestionnaire AdministrationAncillary studies

Timeline

Start date
2023-12-21
Primary completion
2028-12-21
Completion
2028-12-21
First posted
2022-03-23
Last updated
2025-10-20

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05292521. Inclusion in this directory is not an endorsement.